Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury

Biomaterials

Volumn 34, Issue 8, 2013, Pages 1987-1994

  Riegler, Johannes ^a,b   Liew, Aaron ^c   Hynes, Sean O ^c   Ortega, Daniel ^d   O'Brien, Timothy ^c   Day, Richard M ^b   Richards, Toby ^e   Sharif, Faisal ^c   Pankhurst, Quentin A ^b,d   Lythgoe, Mark F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d DAVY FARADAY RESEARCH LABORATORY   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Catheter; Magnetic targeting; Nanoparticle; Restenosis; Stem cell

Indexed keywords

BALLOON ANGIOPLASTY; CELL DELIVERY; CELL RETENTION; CELL VIABILITY; CELLULAR THERAPY; INTERVENTIONAL; MAGNETIC TARGETING; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; NEOINTIMAL HYPERPLASIA; PERIPHERAL ARTERIAL DISEASE; RABBIT MODELS; RESTENOSIS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; VASCULAR DISEASE; VASCULAR INJURY;

CATHETERS; DISEASES; METAL NANOPARTICLES; NANOMAGNETICS; NANOPARTICLES; STEM CELLS; SUPERPARAMAGNETISM;

CELL CULTURE;

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CELL LABELING; CELL VIABILITY; CONTROLLED STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

ADIPOGENESIS; ANIMALS; CELL ADHESION; CHONDROGENESIS; DEXTRANS; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROSCOPY, CONFOCAL; NANOPARTICLES; OSTEOGENESIS; RABBITS; STAINING AND LABELING; VASCULAR SYSTEM INJURIES;

ORYCTOLAGUS CUNICULUS;

EID: 84871525361     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.040     Document Type: Article

References (38)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
2. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
3. Bosch J.L., Hunink M.G. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997, 204:87-96.
4. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease. J Vasc Interv Radiol 2006, 17:1383-1397.
5. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005, 26:804-847.
6. Vroegindeweij D., Vos L.D., Tielbeek A.V., Buth J., vd Bosch H.C. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997, 20:420-425.
7. Landau C., Lange R.A., Hillis L.D. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994, 330:981-993.
8. Libby P., Schwartz D., Brogi E., Tanaka H., Clinton S.K. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992, 86:III47-III52.
9. Monraats P.S., Agema W.R.P., Jukema J.W. Genetic predictive factors in restenosis. Pathol Biol 2004, 52:186-195.
10. Bangalore S., Kumar S., Fusaro M., Amoroso N., Kirtane A.J., Byrne R.A., et al. Outcomes with various drug eluting and bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis fo 22,844 patient years of follow-up from randomised trials. BMJ 2012, 345:e5170.
11. Gulati R., Jevremovic D., Peterson T.E., Witt T.A., Kleppe L.S., Mueske C.S., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003, 108:1520-1526.
12. He T., Smith L.A., Harrington S., Nath K.A., Caplice N.M., Katusic Z.S. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004, 35:2378-2384.
13. Kong D., Melo L.G., Mangi A.A., Zhang L., Lopez-Ilasaca M., Perrella M.A., et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004, 109:1769-1775.
14. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2003, 36:R167.
15. Dames P., Gleich B., Flemmer A., Hajek K., Seidl N., Wiekhorst F., et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol 2007, 2:495-499.
16. Hofmann A., Wenzel D., Becher U.M., Freitag D.F., Klein A.M., Eberbeck D., et al. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A 2009, 106:44-49.
17. Kyrtatos P.G., Lehtolainen P., Junemann-Ramirez M., Garcia-Prieto A., Price A.N., Martin J.F., et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc Interv 2009, 2:794-802.
18. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
19. Riegler J., Lau K.D., Garcia-Prieto A., Price A.N., Richards T., Pankhurst Q.A., et al. Magnetic cell delivery for peripheral arterial disease: a theoretical framework. Med Phys 2011, 38:3932-3943.
20. Fernandez-Aviles F., San Roman J.A., Garcia-Frade J., Fernandez M.E., Penarrubia M.J., de la Fuente L., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004, 95:742-748.
21. Tanaka K., Sata M., Hirata Y., Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 2003, 93:783-790.
22. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003, 93:e17-e24.
23. Forte A., Finicelli M., Mattia M., Berrino L., Rossi F., De Feo M., et al. Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids. J Cell Physiol 2008, 217:789-799.
24. Wang C.H., Cherng W.J., Yang N.I., Kuo L.T., Hsu C.M., Yeh H.I., et al. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 2008, 28:54-60.
25. Sharif F., Hynes S.O., Cooney R., Howard L., McMahon J., Daly K., et al. Gene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol Ther 2008, 16:1674-1680.
26. de Vries I.J., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005, 23:1407-1413.
27. Zhu J., Zhou L., XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med 2006, 355:2376-2378.
28. Freyman T., Polin G., Osman H., Crary J., Lu M., Cheng L., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006, 27:1114-1122.
29. Hou D., Youssef E.A., Brinton T.J., Zhang P., Rogers P., Price E.T., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112:I150-I156.
30. Pislaru S.V., Harbuzariu A., Gulati R., Witt T., Sandhu N.P., Simari R.D., et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol 2006, 48:1839-1845.
31. Polyak B., Fishbein I., Chorny M., Alferiev I., Williams D., Yellen B., et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A 2008, 105:698-703.
32. Arbab A.S., Yocum G.T., Kalish H., Jordan E.K., Anderson S.A., Khakoo A.Y., et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223.
33. Kedziorek D.A., Muja N., Walczak P., Ruiz-Cabello J., Gilad A.A., Jie C.C., et al. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 2010, 63:1031-1043.
34. Toso C., Vallee J.P., Morel P., Ris F., Demuylder-Mischler S., Lepetit-Coiffe M., et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008, 8:701-706.
35. Frank J.A., Miller B.R., Arbab A.S., Zywicke H.A., Jordan E.K., Lewis B.K., et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228:480-487.
36. Loebinger M.R., Kyrtatos P.G., Turmaine M., Price A.N., Pankhurst Q., Lythgoe M.F., et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009, 69:8862-8867.
37. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
38. Pati S., Gerber M.H., Menge T.D., Wataha K.A., Zhao Y., Baumgartner J.A., et al. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLos One 2011, 6:e25171.